−£274k
vs Apr 2024Active - Proposal to Strike off08478748Private limited companyBolton
N2 PHARMACEUTICALS LTD
Significant control: Nikolay Solovyev (75–100%)
Proposal to strike offThe registrar has published a notice proposing to remove this company from the register. Unless the cause is dealt with or an objection is upheld, it can be dissolved. Status as shown on the Companies House register at 31 August 2026; it may have changed since. Check the live record.
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does N2 Pharmaceuticals Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
N2 PHARMACEUTICALS LTD is an active (proposal to strike off) private limited company (company number 08478748) incorporated on 8 April 2013, registered in Bolton. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 April 2025, showing net assets of −£274k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 5% on the prior period (−£260k).
Peer position · net assets
By net assets it sits in the bottom quarter of 138 comparable companies in Manchester (median £436, upper quartile £124k).
02
Ownership and control
- Mr Nikolay Solovyev
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mrs Natalia Romanova-Mossig
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 8 April 201313 yrs ago
- Next accounts due
- 30 January 2027in 99 days
- Confirmation statement due
- 22 April 2027in 181 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
No changevs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | −£274k | — | — | — | — | — | 2 |
| 30 April 2024 | −£260k | — | — | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets below zeroNet assets £-274,316 at 30 April 2025
- Incorporated five or more years agoIncorporated 8 April 2013
- Register status is not ActiveActive - Proposal to Strike off
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 181 days
- Next accounts duein 99 days
- Accounts period endNet liabilities £274k · micro accounts
- Accounts period endNet liabilities £260k · micro accounts
- Incorporated
08
Similar companies in Manchester
- SCOPE INTERNATIONAL (UK) LIMITEDBolton · inc. Apr 2013
- INSECT RESEARCH SYSTEMS LTDNewton Le Willows · inc. Jul 2013
- MICROBIOSENSOR LIMITEDBramhall · inc. Dec 2012
- PERFECTUS BIOMED LTDManchester · inc. Dec 2012
- ALDERLEY ANALYTICAL LTDMacclesfield · inc. Aug 2013
- STRATASTEM LIMITEDMacclesfield · inc. Nov 2012
All companies incorporated on 8 April 2013 · in Apr 2013.
09
Reminders for N2 PHARMACEUTICALS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.